Filing Flows › Core Laboratories (CLB) › Q2 2026 › vs Q1 2026
Core Laboratories (CLB) Q2 2026 vs Q1 2026 (quarter over quarter)
Core Laboratories's revenue rose $2.8M (+2%) from $122M in Q1 2026 to $125M in Q2 2026. The biggest changes: Product +$2.8M (+10%); Service +$25K (0%). Operating margin 7.3% against 1.5% (+5.8 pts).
Core Laboratories, Q2 2026: revenue $125M (-4% year over year), operating margin 7.3%, net earnings $6.0M, operating cash flow $7.8M. The chart draws each line against Q1 2026, the increases inside each band.
Margins
| Q2 2026 | Q1 2026 | Change | |
|---|---|---|---|
| Operating margin | 7.3% | 1.5% | +5.8 pts |
| Net margin | 4.8% | -0.6% | +5.4 pts |
Every line
| Line | Q2 2026 | Q1 2026 | Change | % |
|---|---|---|---|---|
| Service | $94.3M | $94.3M | $25K | 0% |
| Product | $30.3M | $27.5M | $2.8M | +10% |
| Revenue | $125M | $122M | $2.8M | +2% |
| Operating profit | $9.2M | $1.9M | $7.3M | +385% |
| Costs & expenses | $115M | $120M | −$4.5M | -4% |
| Pre-tax earnings | $6.3M | −$1.0M | $7.3M | — |
| Other expense, net | $2.8M | $2.9M | −$45K | -2% |
| Cost of revenue | $101M | $102M | −$702K | -0.7% |
| General & admin | $11.0M | $14.7M | −$3.8M | -26% |
| Other operating costs | $3.1M | $3.1M | $15K | +0.5% |
| Loss borne by minority interests | $158K | −$36K | $194K | — |
| Net earnings | $6.0M | −$789K | $6.7M | — |
| Income tax | $507K | −$251K | $758K | — |
| Depreciation & amortization | $3.8M | $3.8M | $61K | +2% |
| Share-based compensation | $902K | $5.0M | −$4.1M | -82% |
| Working capital & other | $2.9M | $4.0M | −$1.2M | -29% |
| Operating cash flow | $7.8M | $4.0M | $3.8M | +97% |
Questions
How much did Core Laboratories's revenue grow quarter over quarter in Q2 2026?
Core Laboratories's revenue rose $2.8M (+2%) from $122M in Q1 2026 to $125M in Q2 2026.
What drove Core Laboratories's revenue change in Q2 2026?
Product +$2.8M (+10%); Service +$25K (0%).